|
CA2825023A1
|
|
Delivery system and conjugates for compound delivery via naturally occurring intracellular transport routes
|
|
CA2768598A1
|
|
Delivery system and conjugates for compound delivery via naturally occurring intracellular transport routes
|
|
WO2010049173A1
|
|
Use of inhibitors of host kinases for the treatment of infectious diseases
|
|
WO2007101710A1
|
|
Use of inhibitors of scavenger receptor class proteins for the treatment of infectious diseases
|
|
EP1832283A1
|
|
Use of inhibitors of scavenger receptor class proteins for the treatment of infectious diseases
|
|
US2007093438A1
|
|
Use of eukaryotic genes affecting spindle formation or microtubule function during cell division for diagnosis and treatment of proliferative diseases
|
|
WO2005026388A2
|
|
The use of eukaryotic genes affecting chromatin separation for diagnosis and treatment of proliferative diseases
|
|
US2007015161A1
|
|
Use of eukaryotic genes affecting cell cycle control or cell cycle progression for diagnosis and treatment of proliferative diseases
|
|
AU2483802A
|
|
Eukaryotic cell division genes and their use in diagnosis and treatment of proliferative diseases
|
|
AU2791702A
|
|
Genes required for viability and/or reproduction in c. elegans and their use in the development of anti-nematode agents
|
